Characteristics of severe asthma patients included in the French Palomb Cohort
| العنوان: | Characteristics of severe asthma patients included in the French Palomb Cohort |
|---|---|
| المؤلفون: | JESTIN-GUYON, Nolwenn, OUAALAYA, El Hassane, OZIER, Annaig, NOCENT, Cecilia, BERNADY, Alain, NGUYEN, Laurent, BERTEAUD, Emilie, DUPUY-GRASSET, Magali, LE GUILLOU, Frederic, MELLONI, Boris, PORTEL, Laurent, PRUD'HOMME, Anne, DIDIER, Alain, MOLIMARD, Mathieu, GUILLEMINAULT, Laurent, RAHERISON-SEMJEN, Chantal |
| سنة النشر: | 2023 |
| مصطلحات موضوعية: | Asthma management, Environment, Severe asthma, Sciences du Vivant [q-bio]/Santé publique et épidémiologie |
| الوصف: | Background: The prevalence of severe asthma among asthmatic patients is estimated between 5-10% in France. The aim of this work was to describe clinical features of patients included in the French Severe Asthma Palomb cohort. Methods: Patients followed in a real-life context by pulmonologists located in 2 regions since 2019. Inclusion criteria: 1) ⩾18 years-old, 2) >6 months follow-up before inclusion for severe asthma, (GINA, 2019) 3) combination of ICS and LABA and anticholinergic, associated with 4) OCS, anti-IgE based treatment, anti-IL5, anti-RIL5, anti-IL4, anti-IL13, thermoplasty. Results: In January 2023, 214 patients were included. Mean age was 55.1 years old (±16.4). 61.7% were female, 30.0% had a BMI⩾30 (morbid/severe obesity), 29.3% were previous smokers and 4.8% current smokers. 61.4% had an onset of asthma symptoms after the age of 15 and 21.8% had a history of acute severe asthma. 36.8% had dyspnea (mMRC⩾2) and 23.8% had chronic cough (>8 weeks). During the 12 months before inclusion, 25.2% had at least 2 exacerbations (having required a general corticotherapy or an increase in ICS treatment). 29.0% had chronic rhinitis, 22.9% gastro-esophageal reflux disease, 19.2% chronic rhinosinusitis, 14.0% anxiety, 13.6% blood hypertension and 13.1% sleep apnea syndrome. Regarding phenotypes: 46.0% were eosinophilic with allergy and 32.1% were eosinophilic without allergy. 135 patients were already on a biotherapy treatment at inclusion and 26 had a biotherapy introduced at inclusion. Conclusion: These are preliminary results of an observatory of patients followed with severe asthma in the French medical framework. Sponsors: Bordeaux University Foundation, AstraZeneca, Chiesi, GSK, Novartis, Sanofi. |
| نوع الوثيقة: | other/unknown material |
| اللغة: | English |
| تدمد: | 0903-1936 |
| Relation: | https://oskar-bordeaux.fr/handle/20.500.12278/188162 |
| DOI: | 10.1183/13993003.congress-2023.PA4432 |
| الاتاحة: | https://oskar-bordeaux.fr/handle/20.500.12278/188162 https://hdl.handle.net/20.500.12278/188162 https://doi.org/10.1183/13993003.congress-2023.PA4432 |
| Rights: | open ; Pas de Licence CC |
| رقم الانضمام: | edsbas.4E98CE1E |
| قاعدة البيانات: | BASE |
Full Text Finder | ResultId |
1 |
|---|---|
| Header |
edsbas BASE edsbas.4E98CE1E 883 3 unknown 882.976379394531 |
| PLink |
https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsbas&AN=edsbas.4E98CE1E&custid=s6537998&authtype=sso |
| FullText |
Array
(
[Availability] => 0
)
Array ( [0] => Array ( [Url] => https://oskar-bordeaux.fr/handle/20.500.12278/188162# [Name] => EDS - BASE [Category] => fullText [Text] => View record in BASE [MouseOverText] => View record in BASE ) [1] => Array ( [Url] => https://resolver.ebscohost.com/openurl?custid=s6537998&groupid=main&authtype=ip,guest&sid=EBSCO:edsbas&genre=article&issn=09031936&ISBN=&volume=&issue=&date=20230101&spage=&pages=&title=Characteristics of severe asthma patients included in the French Palomb Cohort&atitle=Characteristics%20of%20severe%20asthma%20patients%20included%20in%20the%20French%20Palomb%20Cohort&id=DOI:10.1183/13993003.congress-2023.PA4432 [Name] => Full Text Finder (s6537998api) [Category] => fullText [Text] => Full Text Finder [Icon] => https://imageserver.ebscohost.com/branding/images/FTF.gif [MouseOverText] => Full Text Finder ) ) |
| Items |
Array
(
[Name] => Title
[Label] => Title
[Group] => Ti
[Data] => Characteristics of severe asthma patients included in the French Palomb Cohort
)
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22JESTIN-GUYON%2C+Nolwenn%22">JESTIN-GUYON, Nolwenn</searchLink><br /><searchLink fieldCode="AR" term="%22OUAALAYA%2C+El+Hassane%22">OUAALAYA, El Hassane</searchLink><br /><searchLink fieldCode="AR" term="%22OZIER%2C+Annaig%22">OZIER, Annaig</searchLink><br /><searchLink fieldCode="AR" term="%22NOCENT%2C+Cecilia%22">NOCENT, Cecilia</searchLink><br /><searchLink fieldCode="AR" term="%22BERNADY%2C+Alain%22">BERNADY, Alain</searchLink><br /><searchLink fieldCode="AR" term="%22NGUYEN%2C+Laurent%22">NGUYEN, Laurent</searchLink><br /><searchLink fieldCode="AR" term="%22BERTEAUD%2C+Emilie%22">BERTEAUD, Emilie</searchLink><br /><searchLink fieldCode="AR" term="%22DUPUY-GRASSET%2C+Magali%22">DUPUY-GRASSET, Magali</searchLink><br /><searchLink fieldCode="AR" term="%22LE+GUILLOU%2C+Frederic%22">LE GUILLOU, Frederic</searchLink><br /><searchLink fieldCode="AR" term="%22MELLONI%2C+Boris%22">MELLONI, Boris</searchLink><br /><searchLink fieldCode="AR" term="%22PORTEL%2C+Laurent%22">PORTEL, Laurent</searchLink><br /><searchLink fieldCode="AR" term="%22PRUD'HOMME%2C+Anne%22">PRUD'HOMME, Anne</searchLink><br /><searchLink fieldCode="AR" term="%22DIDIER%2C+Alain%22">DIDIER, Alain</searchLink><br /><searchLink fieldCode="AR" term="%22MOLIMARD%2C+Mathieu%22">MOLIMARD, Mathieu</searchLink><br /><searchLink fieldCode="AR" term="%22GUILLEMINAULT%2C+Laurent%22">GUILLEMINAULT, Laurent</searchLink><br /><searchLink fieldCode="AR" term="%22RAHERISON-SEMJEN%2C+Chantal%22">RAHERISON-SEMJEN, Chantal</searchLink> ) Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2023 ) Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22Asthma+management%22">Asthma management</searchLink><br /><searchLink fieldCode="DE" term="%22Environment%22">Environment</searchLink><br /><searchLink fieldCode="DE" term="%22Severe+asthma%22">Severe asthma</searchLink><br /><searchLink fieldCode="DE" term="%22Sciences+du+Vivant+[q-bio]%2FSanté+publique+et+épidémiologie%22">Sciences du Vivant [q-bio]/Santé publique et épidémiologie</searchLink> ) Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => Background: The prevalence of severe asthma among asthmatic patients is estimated between 5-10% in France. The aim of this work was to describe clinical features of patients included in the French Severe Asthma Palomb cohort. Methods: Patients followed in a real-life context by pulmonologists located in 2 regions since 2019. Inclusion criteria: 1) ⩾18 years-old, 2) >6 months follow-up before inclusion for severe asthma, (GINA, 2019) 3) combination of ICS and LABA and anticholinergic, associated with 4) OCS, anti-IgE based treatment, anti-IL5, anti-RIL5, anti-IL4, anti-IL13, thermoplasty. Results: In January 2023, 214 patients were included. Mean age was 55.1 years old (±16.4). 61.7% were female, 30.0% had a BMI⩾30 (morbid/severe obesity), 29.3% were previous smokers and 4.8% current smokers. 61.4% had an onset of asthma symptoms after the age of 15 and 21.8% had a history of acute severe asthma. 36.8% had dyspnea (mMRC⩾2) and 23.8% had chronic cough (>8 weeks). During the 12 months before inclusion, 25.2% had at least 2 exacerbations (having required a general corticotherapy or an increase in ICS treatment). 29.0% had chronic rhinitis, 22.9% gastro-esophageal reflux disease, 19.2% chronic rhinosinusitis, 14.0% anxiety, 13.6% blood hypertension and 13.1% sleep apnea syndrome. Regarding phenotypes: 46.0% were eosinophilic with allergy and 32.1% were eosinophilic without allergy. 135 patients were already on a biotherapy treatment at inclusion and 26 had a biotherapy introduced at inclusion. Conclusion: These are preliminary results of an observatory of patients followed with severe asthma in the French medical framework. Sponsors: Bordeaux University Foundation, AstraZeneca, Chiesi, GSK, Novartis, Sanofi. ) Array ( [Name] => TypeDocument [Label] => Document Type [Group] => TypDoc [Data] => other/unknown material ) Array ( [Name] => Language [Label] => Language [Group] => Lang [Data] => English ) Array ( [Name] => ISSN [Label] => ISSN [Group] => ISSN [Data] => 0903-1936 ) Array ( [Name] => NoteTitleSource [Label] => Relation [Group] => SrcInfo [Data] => https://oskar-bordeaux.fr/handle/20.500.12278/188162 ) Array ( [Name] => DOI [Label] => DOI [Group] => ID [Data] => 10.1183/13993003.congress-2023.PA4432 ) Array ( [Name] => URL [Label] => Availability [Group] => URL [Data] => https://oskar-bordeaux.fr/handle/20.500.12278/188162<br />https://hdl.handle.net/20.500.12278/188162<br />https://doi.org/10.1183/13993003.congress-2023.PA4432 ) Array ( [Name] => Copyright [Label] => Rights [Group] => Cpyrght [Data] => open ; Pas de Licence CC ) Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsbas.4E98CE1E ) |
| RecordInfo |
Array
(
[BibEntity] => Array
(
[Identifiers] => Array
(
[0] => Array
(
[Type] => doi
[Value] => 10.1183/13993003.congress-2023.PA4432
)
)
[Languages] => Array
(
[0] => Array
(
[Text] => English
)
)
[Subjects] => Array
(
[0] => Array
(
[SubjectFull] => Asthma management
[Type] => general
)
[1] => Array
(
[SubjectFull] => Environment
[Type] => general
)
[2] => Array
(
[SubjectFull] => Severe asthma
[Type] => general
)
[3] => Array
(
[SubjectFull] => Sciences du Vivant [q-bio]/Santé publique et épidémiologie
[Type] => general
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Characteristics of severe asthma patients included in the French Palomb Cohort
[Type] => main
)
)
)
[BibRelationships] => Array
(
[HasContributorRelationships] => Array
(
[0] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => JESTIN-GUYON, Nolwenn
)
)
)
[1] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => OUAALAYA, El Hassane
)
)
)
[2] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => OZIER, Annaig
)
)
)
[3] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => NOCENT, Cecilia
)
)
)
[4] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => BERNADY, Alain
)
)
)
[5] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => NGUYEN, Laurent
)
)
)
[6] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => BERTEAUD, Emilie
)
)
)
[7] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => DUPUY-GRASSET, Magali
)
)
)
[8] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => LE GUILLOU, Frederic
)
)
)
[9] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => MELLONI, Boris
)
)
)
[10] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => PORTEL, Laurent
)
)
)
[11] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => PRUD'HOMME, Anne
)
)
)
[12] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => DIDIER, Alain
)
)
)
[13] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => MOLIMARD, Mathieu
)
)
)
[14] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => GUILLEMINAULT, Laurent
)
)
)
[15] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => RAHERISON-SEMJEN, Chantal
)
)
)
)
[IsPartOfRelationships] => Array
(
[0] => Array
(
[BibEntity] => Array
(
[Dates] => Array
(
[0] => Array
(
[D] => 01
[M] => 01
[Type] => published
[Y] => 2023
)
)
[Identifiers] => Array
(
[0] => Array
(
[Type] => issn-print
[Value] => 09031936
)
[1] => Array
(
[Type] => issn-locals
[Value] => edsbas
)
[2] => Array
(
[Type] => issn-locals
[Value] => edsbas.oa
)
)
)
)
)
)
)
|
| IllustrationInfo |